AstraZeneca launches blood pressure drug in US
AstraZeneca has launched Dutoprol (metoprolol succinate extended release/hydrochlorothiazide) tablets for high blood pressure in the US.
Dutoprol contains the active ingredient of Toprol-XL (metoprolol succinate) plus a low-dose diuretic (also known as a water pill) that provides proven blood pressure lowering at 24 hours.
Toprol-XL is permitted for the treatment of high blood pressure. It may be used alone or in combination with other medications to treat high blood pressure.
AstraZeneca foundation brands executive director Steve Davis said: "DUTOPROL may provide another treatment option for patients with hypertension. We have launched DUTOPROL so patients now have the option to receive a branded combination medicine, in a convenient, once-a-day tablet."
Drug Research Drug Delivery Drug Discovery & Development
Contract Research & Services Clinical Trials Contract Research Contract Services
Automation IT & Software Laboratory Instrumentation
Inward Investment Packaging Regulatory Affairs
This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $0